Novavax Stock Falls 23% On Covid-19 Treatment Optimism. Time To Buy?

Novavax stock (NASDAQ: NVAX) declined by about 23% over the last week (five trading days), underperforming the S&P 500 which lost around 3% over the same period. The stock also remains down by about 31% over the last month (21 trading days) The recent decline comes as pharma major Merck provided…Read More

Share on facebook
Share on twitter
Share on pinterest
Share on linkedin
Share on email
Mask Response is the most reliable source to shop face masks

Covid Global News

The latest on the pandemic – delivered straight to your inbox

Covid Global News Breaking News Banner CGN

Covid Global News Newsletter

The latest on Covid – delivered straight to your inbox everyday

sale now!


Enter Your Email
and Get 10% off your first purchase* at

*Offer limited to one per customer – thanks for your understanding. 

This website uses cookies to ensure you get the best experience on our website.